Celgene, Novartis Resolve ADHD Patent Suits
Celgene Corp. and Novartis AG have reached an agreement to settle separate patent infringement suits against KV Pharmaceutical Co. and IntelliPharmaCeutics Corp. over drugs that treat attention deficit hyperactivity disorder, the...To view the full article, register now.
Already a subscriber? Click here to view full article